The effect of pramlintide, an antidiabetic amylin analogue, on angiogenesis-related markers in vitro

BACKGROUND AND PURPOSE: Irregularities of angiogenesis may participate in the pathogenesis of diabetes complications. Pramlintide is an amylin analogue administered for the treatment of type 1 and type 2 diabetes. The present investigation aimed at surveying the effect of pramlintide on angiogenesis...

Descripción completa

Detalles Bibliográficos
Autores principales: Safaeian, Leila, Vaseghi, Golnaz, Mirian, Mina, Firoozabadi, Mehdi Dehghani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714014/
https://www.ncbi.nlm.nih.gov/pubmed/33312210
http://dx.doi.org/10.4103/1735-5362.293510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714014/
https://www.ncbi.nlm.nih.gov/pubmed/33312210
http://dx.doi.org/10.4103/1735-5362.293510

Ejemplares similares